SAMSUNG PHARM. Co., Ltd.
KSC: 001360.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sung Tag Jung
- Employees
- 240
- Headquarters
- Hwaseong-si, South Korea
- IPO year
- 2000
- Market cap
- ₩171.8B
- Website
- https://www.sspharm.co.kr
Loading 001360…
Loading profile data…Frequently asked questions about 001360
What does SAMSUNG PHARM. Co., Ltd. (001360.KS) do?
SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal m...
Where does 001360.KS trade?
SAMSUNG PHARM. Co., Ltd. (001360.KS) trades on the Korea Exchange.
What sector is 001360.KS in?
SAMSUNG PHARM. Co., Ltd. (001360.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of SAMSUNG PHARM. Co., Ltd.?
Sung Tag Jung is the chief executive officer of SAMSUNG PHARM. Co., Ltd. (001360.KS).
Where is SAMSUNG PHARM. Co., Ltd. headquartered?
SAMSUNG PHARM. Co., Ltd. is headquartered in South Korea.
Does 001360.KS pay a dividend?
SAMSUNG PHARM. Co., Ltd. (001360.KS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 001360.KS go public?
SAMSUNG PHARM. Co., Ltd. (001360.KS) completed its initial public offering in 2000.